After close coordination and intense consultation with the Department of Health , Food and Drug Administration and other concerned agencies, the DDB approved Board Regulation No. 8, Series of 2019 that provides the issuance of license to acquire, possess and use drug products containing dangerous drugs that are not registered in the Philippines but are registered in other countries.
Previously, under the Compassionate Special Permit for Restricted Use of Unregistered Drug and Device Product/Preparation by the FDA , only specialized institution or specialty society can file a request for Compassionate Special Permit. Apart from improving access to dangerous drugs for medical purposes, DDB Chairman Catalino Cuy cited the urgency to ensure that only registered products that have been proven safe for use will be allowed under these regulations.
Office of Mr Fentanyl